YANTAI, China, Aug. 19, 2025 /PRNewswire/ --?RemeGen Co., Ltd. (Stock Code: 688331.SH/09995.HK, "Re...
YANTAI, China, Aug. 13, 2025 /PRNewswire/ -- On August 13th,?Remegen (688331.SH/09995.HK) announced...
YANTAI, China, Aug. 8, 2025 /PRNewswire/ -- On August 8th, RemeGen Co., Ltd. (688331.SH/09995.HK) a...
YANTAI, China, June 17, 2025 /PRNewswire/ -- On June 16, 2025,?RemeGen Co., Ltd. ("RemeGen", stock ...
YANTAI, China, June 3, 2025 /PRNewswire/ -- On June 2 (Chicago time), in an oral presentation at th...
YANTAI, China, May 27, 2025 /PRNewswire/ -- On May 27,?RemeGen Co., Ltd.(688331.SH / 09995.HK) anno...
YANTAI, China, May 12, 2025 /PRNewswire/ -- On May 12th, 2025, RemeGen Co., Ltd. ("RemeGen", stock ...
YANTAI, China, April 9, 2025 /PRNewswire/ --?On April 8, 2025 (UTC-7), impressive results of the Ph...
YANTAI, China, Feb. 15, 2025 /PRNewswire/ -- On the morning of February 14, 2025 (UTC-8), at the on...
YANTAI, China, Jan. 8, 2025 /PRNewswire/ --?On Janurary 7th, 2025, Annals of Oncology (IF: 56.7), a...
YANTAI, China, Dec. 13, 2024 /PRNewswire/ -- On the morning of December 12, 2024 (UTC-6), at the Po...
YANTAI, China, Dec. 12, 2024 /PRNewswire/ -- On the morning of December 12, 2024 (UTC-6), at the Po...
YANTAI, China, Oct. 29, 2024 /PRNewswire/ -- RemeGen Co. Ltd. ("RemeGen" or "the Company") (9995.HK...
YANTAI, China, Aug. 6, 2024 /PRNewswire/ -- RemeGen Co. Ltd. /www.remegen.com/>?("RemeGen" o...
YANTAI,?China, June 5, 2024 /PRNewswire/ -- RemeGen Co., Ltd. /www.remegen.com/>?("RemeGen" ...
YANTAI, China, June 4, 2024 /PRNewswire/ --?RemeGen Co., Ltd. /www.remegen.com/>?("RemeGen" ...
YANTAI, China, May 21, 2024 /PRNewswire/ -- RemeGen Co. Ltd. /www.remegen.com/>?("RemeGen" o...
The biotech company continues to offer hope to systemic lupus erythematosus?( SLE) patients globally...
YANTAI, China, April 3, 2024 /PRNewswire/ -- RemeGen Co. Ltd. /www.remegen.com/> ("RemeGen" ...
YANTAI, China, March 11, 2024 /PRNewswire/ -- RemeGen Co. Ltd. /www.remegen.com/>("RemeGen" ...